These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29866840)

  • 1. PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.
    de Semir D; Bezrookove V; Nosrati M; Dar AA; Wu C; Shen J; Rieken C; Venkatasubramanian M; Miller JR; Desprez PY; McAllister S; Soroceanu L; Debs RJ; Salomonis N; Schadendorf D; Cleaver JE; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5766-E5775. PubMed ID: 29866840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis.
    De Semir D; Nosrati M; Bezrookove V; Dar AA; Federman S; Bienvenu G; Venna S; Rangel J; Climent J; Meyer Tamgüney TM; Thummala S; Tong S; Leong SP; Haqq C; Billings P; Miller JR; Sagebiel RW; Debs R; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2012 May; 109(18):7067-72. PubMed ID: 22511720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHIP drives glioblastoma motility and invasion by regulating the focal adhesion complex.
    de Semir D; Bezrookove V; Nosrati M; Scanlon KR; Singer E; Judkins J; Rieken C; Wu C; Shen J; Schmudermayer C; Dar AA; Miller JR; Cobbs C; Yount G; Desprez PY; Debs RJ; Salomonis N; McAllister S; Cleaver JE; Soroceanu L; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9064-9073. PubMed ID: 32273388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Elevated
    Bezrookove V; Nosrati M; Miller JR; De Semir D; Dar AA; Vosoughi E; Vaquero E; Sucker A; Lazar AJ; Gershenwald JE; Davies MA; Schadendorf D; Kashani-Sabet M
    Clin Cancer Res; 2018 Sep; 24(17):4119-4125. PubMed ID: 29776954
    [No Abstract]   [Full Text] [Related]  

  • 6. Let‑7 miRNAs sensitize breast cancer stem cells to radiation‑induced repression through inhibition of the cyclin D1/Akt1/Wnt1 signaling pathway.
    Sun H; Ding C; Zhang H; Gao J
    Mol Med Rep; 2016 Oct; 14(4):3285-92. PubMed ID: 27574028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.
    Park S; Sung Y; Jeong J; Choi M; Lee J; Kwon W; Jang S; Park SJ; Kim HS; Lee MH; Kim DJ; Liu K; Kim SH; Dong Z; Ryoo ZY; Kim MO
    Oncotarget; 2017 Jun; 8(23):37115-37127. PubMed ID: 28415749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.
    Zhang X; Zhou H; Cai L; Fan C; Liu Y; Wang L; Li Q; Miao Y
    Mol Carcinog; 2017 Sep; 56(9):2058-2065. PubMed ID: 28398603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
    Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
    Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
    Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
    Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting a cell state common to triple-negative breast cancers.
    Muellner MK; Mair B; Ibrahim Y; Kerzendorfer C; Lechtermann H; Trefzer C; Klepsch F; Müller AC; Leitner E; Macho-Maschler S; Superti-Furga G; Bennett KL; Baselga J; Rix U; Kubicek S; Colinge J; Serra V; Nijman SM
    Mol Syst Biol; 2015 Feb; 11(1):789. PubMed ID: 25699542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
    Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients.
    Sterlacci W; Fiegl M; Hilbe W; Jamnig H; Oberaigner W; Schmid T; Augustin F; Auberger J; Obermann EC; Tzankov A
    J Thorac Oncol; 2010 Sep; 5(9):1325-36. PubMed ID: 20631637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
    Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
    Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells.
    Shrivastava S; Kulkarni P; Thummuri D; Jeengar MK; Naidu VG; Alvala M; Redddy GB; Ramakrishna S
    Apoptosis; 2014 Jul; 19(7):1148-64. PubMed ID: 24729100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer.
    Wang HH; Wang YC; Wu DW; Hung CS; Chen CY; Lee H
    Tumour Biol; 2017 Apr; 39(4):1010428317694316. PubMed ID: 28378642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
    Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
    Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer.
    Wu J; Sun Z; Sun H; Li Y
    Mol Med Rep; 2018 Jan; 17(1):562-570. PubMed ID: 29115608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.